Brief: Medicalgorithmics Says DeepRhythm Platform Approved By FDA For U.S. Markets
24/06/2024 06:18
June 24 (Reuters) - Medicalgorithmics SA MDG.WA :
* FDA GREENLIGHTS COMPANY'S DEEPRHYTHM PLATFORM FOR US MARKETS
* FDA'S APPROVAL ALLOWS FOR COMMERCIALISATION OF PLATFORM
Source text for Workspace: urn:newsml:reuters.com:*:nEM7Xb5N8a
Further company coverage: MDG.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Medicalgorithmics SA
See all newsBrief: Medicalgorithmics Signs Deal With US Med-Tech Partner For ECG Analysis Services In The United States
Brief: Medicalgorithmics Proposes Share Capital Increase Via Two Emissions Of R and S Series Shares
Brief: Poland's Medicalgorithmics Signs LOI For Potential $67 Mln Takeover By US Nasdaq-Listed Firm
Brief: Medicalgorithmics Estimates Q3 Sales Revenue At 10.9 Million Zlotys
Brief: Medicalgorithmics Q2 Net Profit At 0.1 Mln Zlotys